申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP2423194A1
公开(公告)日:2012-02-29
Provided is a heterocyclic derivative showing a thyroid hormone β receptor agonist action, which is effective for the prophylaxis or treatment of the diseases relating to the action. A compound represented by the formula [I]:
wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, and a medicament containing the compound as an active ingredient.
本发明提供了一种杂环衍生物,它具有甲状腺激素β受体激动剂的作用,可有效预防或治疗与该作用有关的疾病。由式[I]代表的化合物:
其中各符号如说明书中所定义的化合物、其药理学上可接受的盐,以及含有该化合物作为活性成分的药物。